December 12, 2019

FOCUS ON WET AMD

Research targets gene therapy for exudative AMD patients Two anti-VEGF gene therapies are being investigated in clinical trials of patients with exudative age-related macular degeneration. Initial efficacy and safety results are encouraging, says Szilárd Kiss, MD. Read on ADVERTISEMENT

Anti-VEGF injections + glaucoma: Surgeons must watch IOP elevation Acute rises in IOP that occur with anti-VEGF injections is a real phenomenon, but it is transient and may not necessarily warrant any intervention for many patients, according to Matthew Schlenker MD, MSc. Read more